MedPath
NMPA Approval

Atosiban Acetate Injection

国药准字H20254204

May 20, 2025

Drug Information

醋酸阿托西班注射液

注射剂

5ml:37.5mg(按C₄₃H₆₇N₁₁O₁₂S₂计)

化学药品

May 20, 2025

Company Information

Applicant Company

安徽省合肥市长江西路669号高新区海关路K-1

Manufacturing Company

南京市江北新区科创大道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

醋酸阿托西班注射液 - NMPA 批准文号 | MedPath